Clinical Trial Update: Cholecalciferol in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cholecalciferol (vitamin D3) for treating patients with myelodysplastic syndromes, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED